4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001596771-20-000110
VP of Corp. Dev. and Secretary acquired 100,120 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoffmann Bernhard VP of Corp. Dev. and Secretary | 2020-11-05 | Grant or award | +100,120 | 100,120 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hoffmann Bernhard VP of Corp. Dev. and Secretary | 2020-11-05 | Grant or award · Employee Stock Option (right to buy) | +42,867 | 42,867 | D: show line 2 in the form | ||
| Hoffmann Bernhard VP of Corp. Dev. and Secretary | 2020-11-05 | Grant or award · Employee Stock Option (right to buy) | +30,110 | 30,110 | D: show line 3 in the form | ||
| Hoffmann Bernhard VP of Corp. Dev. and Secretary | 2020-11-05 | Grant or award · Employee Stock Option (right to buy) | +4,226 | 4,226 | D: show line 4 in the form |
Loading xslF345X03/primary_doc.xml…